SCHEMBL2807717

SCHEMBL2807717

C=CCSC(=S)SSC(=S)SCC=C

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
ALOX5 P09917 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MITF O75030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5796214 0.88 ALDH1A1 (0.42) TRPA1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL10968157 0.79
SCHEMBL461758 0.78
SCHEMBL10972124 0.77
SCHEMBL2522347 0.76
Ammonia Solution, Strong SCHEMBL10336276 0.76
SCHEMBL1766014 0.76
SCHEMBL11666652 0.76
SCHEMBL9498800 0.76
SCHEMBL1901075 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745017-B1 SYNTHESIS OF TRITHIOCARBONATE RAFT GENTS AND INTERMEDIATES THEREOF DU PONT (US) 2010-04-14 EP disclosed
US-7632966-B2 Reacting thiol with sodium or potassium t-butoxide, carbon disulfide and iodine in solvent mixture; bis(alkylsulfanylthiocarbonyl) disulfides as intermediates; for living polymerization of methacrylates; low polydispersity E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-12-15 US disclosed
US-7632966-B2 Reacting thiol with sodium or potassium t-butoxide, carbon disulfide and iodine in solvent mixture; bis(alkylsulfanylthiocarbonyl) disulfides as intermediates; for living polymerization of methacrylates; low polydispersity E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-12-15 US disclosed
US-20080039651-A1 Synthesis Of Trithiocarbonate Raft Agents And Intermediates Thereof DUPONT ELECTRONICS, INC. 2008-02-14 US disclosed
US-20080039651-A1 Synthesis Of Trithiocarbonate Raft Agents And Intermediates Thereof DUPONT ELECTRONICS, INC. 2008-02-14 US disclosed
EP-1745017-A1 SYNTHESIS OF TRITHIOCARBONATE RAFT GENTS AND INTERMEDIATES THEREOF E.I.Du pont de nemours and company (US) 2007-01-24 EP disclosed
EP-1745017-A1 SYNTHESIS OF TRITHIOCARBONATE RAFT GENTS AND INTERMEDIATES THEREOF E.I.Du pont de nemours and company (US) 2007-01-24 EP disclosed
WO-2005113493-A1 SYNTHESIS OF TRITHIOCARBONATE RAFT GENTS AND INTERMEDIATES THEREOF E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-12-01 WO disclosed
WO-2005113493-A1 SYNTHESIS OF TRITHIOCARBONATE RAFT GENTS AND INTERMEDIATES THEREOF E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039651-A1 Synthesis Of Trithiocarbonate Raft Agents And Intermediates Thereof STS, TST, CBS TRPA1 1175/4885ALDH1A1 2743/4885CYP3A4 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.